Bromelain Enzyme Powder

Most enzyme ingredients on the B2B market are sold on activity numbers alone. The problem is that a GDU figure printed on a spec sheet tells you almost nothing about how a bromelain preparation will actually perform in your formulation - its thermal stability under processing conditions, its residual activity after encapsulation, or whether the activity was measured against a standardized substrate or a loosely defined internal method.

Bromelain Enzyme Powder is one of the most commercially versatile proteolytic enzymes in the nutraceutical and food ingredient toolkit, yet it is also one of the most frequently misspecified. Derived from the stem of Ananas comosus, bromelain is not a single enzyme but a complex of related cysteine proteases - a distinction that matters enormously when you are designing a product for a specific therapeutic endpoint or a food processing application with tight pH and temperature windows.

At Jiuyuan Bio, we produce bromelain from pineapple stem through a low-temperature aqueous extraction and multi-stage purification process that preserves native enzyme conformation. Our standard commercial grades range from 100 GDU/g to 3,600 GDU/g, with pharmaceutical-grade isolates available upon request. Every batch is activity-tested by the GDU method against gelatin substrate under controlled conditions - not estimated by protein content - so the number on our COA reflects actual catalytic performance.

This page is intended for R&D formulators, procurement managers, and contract manufacturers who need to understand not just what bromelain is, but how to select the right grade, avoid common sourcing pitfalls, and build a defensible product around it.

Standard Grades Available

Activity unit note: GDU (Gelatin Digesting Units) is the most widely used commercial standard for bromelain. FIP units (Fédération Internationale Pharmaceutique) are preferred in European pharmaceutical submissions. We can provide dual-unit COAs (GDU + FIP) upon request.

Full Analytical Profile - Representative COA (2,400 GDU/g Grade)

Custom specifications - including enteric-coated granules, microencapsulated formats, and excipient-blended premixes - are available with a minimum lead time of 15 business days.

Bromelain Enzyme Powder is not a single molecular entity - it is a heterogeneous mixture of proteolytic and non-proteolytic components, and understanding this complexity is essential for formulators targeting specific biological endpoints.

Stem Bromelain (EC 3.4.22.32) - The Principal Protease

The dominant cysteine protease in commercial bromelain preparations, stem bromelain accounts for the majority of the proteolytic activity measured by GDU assay. It cleaves peptide bonds on the carboxyl side of basic and aromatic amino acid residues, making it effective across a broad substrate range.

Fruit Bromelain (EC 3.4.22.33)

Present in pineapple fruit but largely absent in stem-derived commercial preparations. Some research has examined differential substrate specificity between stem and fruit isoforms, though commercial supply is almost exclusively stem-derived.

Ananain & Comosain

Minor cysteine proteases co-extracted with stem bromelain. Their individual contributions to the biological activity of commercial preparations are not fully characterized, but they are considered part of the "bromelain complex" in most pharmacological literature.

Non-Proteolytic Components

Commercial bromelain preparations also contain:

● Peroxidase - antioxidant enzyme activity

● Acid phosphatase - phosphate ester hydrolysis

● Protease inhibitors - endogenous regulatory proteins

● Organically bound calcium - structural role in enzyme stability

Formulator's note: The non-proteolytic components are largely retained in lower-grade (100–1,200 GDU/g) preparations and progressively removed in higher-purity grades. For applications where only proteolytic activity matters (e.g., meat tenderization, protein hydrolysis), high-activity grades are preferred. For nutraceutical applications where the broader enzyme complex may contribute to the observed clinical effects, mid-range grades (1,200–2,400 GDU/g) offer a reasonable balance.

Regulatory Positioning by Market

● United States: Generally Recognized as Safe (GRAS) status for food use; marketed as a dietary supplement ingredient under DSHEA. No novel food restrictions.

● European Union: Approved food enzyme under Regulation (EC) No 1332/2008; check specific national transposition for supplement applications.

● Canada: Natural Health Product (NHP) classification; monograph review recommended.

● Australia: Listed medicine ingredient under TGA; ARTG listing pathway applicable.

Enzyme ingredients present a specific QC challenge that most botanical extracts do not: activity is not stable. A Bromelain Enzyme Powder that tests at 2,400 GDU/g on day one can degrade significantly if exposed to moisture, heat, or oxidative conditions during storage or transit. Our QC program is designed around this reality.

In-Process Controls

● Raw material moisture and activity pre-screening before extraction

● Temperature logging at every critical processing stage (extraction, concentration, drying)

● In-process activity checks at the concentration step to verify yield trajectory

● pH monitoring throughout extraction and purification

Finished Product Testing

Every released batch is accompanied by a Certificate of Analysis (COA) covering:

● Enzyme activity (GDU/g by gelatin substrate assay; FIP available on request)

● Physical characteristics (appearance, odor, particle size, moisture)

● Protein content (Kjeldahl method)

● Microbial enumeration (TPC, Y&M, E. coli, Salmonella, Staphylococcus aureus)

● Heavy metals (ICP-MS: Pb, Cd, As, Hg)

● Pesticide residues (GC-MS/MS, EU MRL compliant)

● Solvent residues (GC headspace, ICH Q3C)

Instrumentation

Cold-Chain & Stability Considerations

Bromelain activity follows Arrhenius kinetics - every 10 °C increase in storage temperature roughly doubles the rate of activity loss. We recommend:

● Storage at ≤8 °C for long-term inventory (12+ months)

● Storage at ≤25 °C acceptable for short-term use (≤6 months)

● Avoid repeated freeze-thaw cycles for reconstituted solutions

● Nitrogen-flushed packaging is standard on all shipments

Grade-to-Grade Comparison

Bromelain vs. Comparable Proteolytic Enzyme Ingredients

Bromelain's distinguishing profile is its combination of broad pH tolerance, dual food-and-supplement regulatory status, and a substantial clinical literature base - making it one of the most versatile and commercially de-risked enzyme ingredients available to formulators today.

Our manufacturing complex covers 70,000 m² with:

● 10 automated production lines

● Plate-frame and high-speed centrifugation systems

● Membrane purification systems

● Freeze-drying & spray-drying lines

● 100,000-grade cleanroom area

● 6000+ tons annual capacity

Quality is ensured through:

● Advanced enzymology testing center

● Full traceability for every batch

● Strict adherence to cGMP & HACCP processes

Full documentation packages, including third-party verification reports, are available to qualified buyers under NDA.

Storage: Keep in a cool, dry, and clean place, protected from moisture and direct light. Bulk Package: 25kg/drum. Lead Time: 7 days after your order. Shelf Life: 2 years. Remark: Customized specifications can also be achieved.

Q1: What is the difference between Bromelain Enzyme Powder from pineapple stem and pineapple fruit?

Commercially available bromelain is almost exclusively derived from pineapple stem, not fruit. Stem bromelain (EC 3.4.22.32) and fruit bromelain (EC 3.4.22.33) are distinct enzymes with different substrate specificities and molecular weights. Stem tissue contains significantly higher protease concentrations than fruit, which is why the stem is the economically viable source for bulk enzyme production. When a supplier does not specify stem vs. fruit origin, assume stem - but ask anyway.

Q2: How should bromelain be incorporated into capsule or tablet formulations without losing activity?

Several formulation factors can degrade bromelain activity during manufacturing: excessive compression force in tableting, heat generated during granulation, and moisture uptake during blending. Best practices include: using direct compression where possible, keeping processing temperatures below 40 °C, incorporating a desiccant in the packaging, and conducting finished-product activity testing (not just raw material testing) to verify that manufacturing did not cause significant activity loss.

Q3: Can bromelain be used in enteric-coated formulations for systemic absorption?

Yes, and this is a well-established approach. Bromelain is partially degraded by gastric acid at low pH, so enteric coating protects the enzyme through the stomach and allows release in the small intestine - where it can be absorbed intact. Studies have confirmed that bromelain can be absorbed from the GI tract and detected in plasma, which is relevant for its systemic anti-inflammatory applications. We offer enteric-coated granule formats upon request.

Q4: What is the clinical evidence base for bromelain in anti-inflammatory applications?

The anti-inflammatory evidence for bromelain is more developed than for most enzyme ingredients. Randomized controlled trials have examined bromelain in the context of post-surgical edema, osteoarthritis (particularly knee), sinusitis, and sports-related soft tissue injury. A frequently cited meta-analysis published in Evidence-Based Complementary and Alternative Medicine (2016) reviewed multiple RCTs and concluded that bromelain demonstrated statistically significant effects on pain and swelling in musculoskeletal conditions. The evidence base, while not at the level of pharmaceutical drugs, is substantially stronger than for many botanical anti-inflammatory ingredients. Formulators should calibrate label claims to the available evidence and consult regulatory counsel for their specific market.

Q5: Is bromelain stable in liquid formulations such as functional beverages?

Bromelain activity in aqueous solution is pH- and temperature-dependent. At neutral pH (6.5–7.5) and refrigerated temperatures (2–8 °C), activity is reasonably stable over weeks. At ambient temperature or in acidic beverage matrices (pH < 4.0), activity loss is significant and rapid. For functional beverage applications, microencapsulation or enteric-coating of the enzyme is strongly recommended to protect activity through the product's shelf life. We can provide encapsulated formats optimized for beverage pH ranges - contact our technical team with your target formulation parameters.

Q6: How does bromelain interact with common supplement co-ingredients?

Bromelain is generally compatible with most nutraceutical co-ingredients, but a few interactions warrant attention:

● Quercetin: Often co-formulated with bromelain; quercetin may enhance bromelain's anti-inflammatory activity through complementary mechanisms (COX-2 inhibition vs. protease-mediated pathway modulation).

● Blood-thinning agents: Bromelain has demonstrated mild anticoagulant properties in some studies. Formulators targeting products for populations on anticoagulant therapy should include appropriate label warnings.

● Other proteases (papain, serrapeptase): Can be co-formulated; ensure total proteolytic activity is within the intended therapeutic range.

Q7: What documentation do you provide for EU regulatory submissions?

For EU-bound shipments, we routinely provide: full COA with GDU and FIP activity data, heavy metal and pesticide residue reports (EU MRL compliant), solvent residue report (ICH Q3C), allergen and GMO declarations, product specification sheet, and manufacturing process description. For food enzyme applications under Regulation (EC) No 1332/2008, we can provide botanical identity documentation and production process descriptions. Additional dossier requirements should be discussed with our technical team prior to order placement.

Q8: Do you offer private-label or OEM blending services for enzyme-based products?

Yes. Jiuyuan Bio operates a dedicated OEM/ODM division capable of formulating, blending, and packaging custom digestive enzyme complexes, sports recovery blends, and anti-inflammatory enzyme stacks incorporating bromelain. We have completed OEM projects for clients in North America, Europe, and Australia. Typical OEM MOQ is 50 kg of finished blend; lead time is 20–30 business days after formula confirmation and raw material approval.

Jiuyuan Biotech supplies Bromelain Enzyme Powder to food manufacturers, supplement brands, and contract formulators across North America, Europe, and the Asia-Pacific region. Our technical team - not a generic sales inbox - handles every inquiry.

Email: info@jiuyuanbio.com

Website: www.jiuyuanbio.com

Request: Sample | Bulk Quote | CoA & Spec Sheet |

Standard response time: within 1 business day. Please include your target application and annual volume estimate for the most relevant technical recommendation.